This CME-accredited symposium took place during the ISTH virtual congress on 20th July 2021. Watch the video and download the slides to understand all of the practical considerations relating to the use of TPO-RAs in ITP.


This accredited, virtual symposium took place on Tuesday 20th July 12:30-13:30 EST; 17:30-18:30 CET. A recording of the event will be available for 90 days at ISTH 2021.

The Practical considerations around the use of TPO-RAs in ITP, Philadelphia (virtual meeting), United States, 20/07/2021-20/07/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities. Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

For any queries, please contact iain.murdoch@cor2ed.com

Dr Hanny Al-Samkari is an Assistant Professor of Medicine at Harvard Medical School and clinical investigator in the Massachusetts General Hospital (MGH) Division of Hematology. He also serves as the Associate Director of the MGH Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence. His clinical and research interests are in hemostasis, thrombosis, and hemolysis, with focuses in immune thrombocytopenia, HHT, anti-angiogenic therapeutics, and hereditary hemolytic anemias. He also does research into novel indications for the thrombopoietin receptor agonists. He currently serves as PI for several clinical trials in these areas.

Waleed Ghanima is Head of Research and a Consultant Haematologist at Østfold Hospital, Norway and a Professor in the Institute of Clinical Medicine, University of Oslo, Norway. Dr Ghanima gained his medical degree from the College of Medicine, University of Baghdad, Iraq. He joined Østfold Hospital in 2001, becoming a Consultant Haematologist in 2004, assuming his current position as Head of Research in 2014. Professor Ghanima’s main research field is venous thrombosis and immune thrombocytopenia (ITP). He has published more than 120 articles in national and international peer-reviewed journals.

Dr Hillary Maitland is an Associate Professor of Medicine in the division of Hematology Oncology at the University of Virginia Emily Couric Clinical Cancer Center in Charlottesville Virginia. Her clinical focus is in the treatment of patients with non-malignant hematologic conditions, particularly those with disorders of hemostasis. She leads the hospital’s quality coalition for anticoagulation and thrombosis prevention. Her research focus is on quality and safety of anticoagulant therapies, treatment and prevention of thrombosis.

Programme summary
Play the video now
Other episodes in this series
Share this programme
This educational programme is supported by an Independent Medical Education Grant from Sobi
Accreditation
EACCME
This course has been accredited by EACCME® for ECMEC®.
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

podcast Podcast

Episode

4

of 4

episode
Hemostasis and bleeding disorders 
Perioperative thromboprophylaxis revisited

Minimising the risk of thrombosis in surgical patients

Experts
Prof. Dimitrios Tsakiris, Prof. Daniel Bolliger
  • download Downloadable
    Resouces
  • clock 19 MIN
  • calendar Nov 2023

Educational programme supported by an independent medical education grant from Viatris.
podcast Podcast

Episode

3

of 4

episode
Hemostasis and bleeding disorders 
VTE: What is the optimal duration of antithrombotic treatment?

Part 3 of a 4-part series on thrombosis

Experts
Prof. Dimitrios Tsakiris, Prof. Jerzy Windyga
Endorsed by
Fundacja Trombofilia i Zakrzepica
  • download Downloadable
    Resouces
  • clock 26 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Viatris.
podcast Podcast

Episode

2

of 4

episode
Hemostasis and bleeding disorders Oncology 
Cancer and Thrombosis

A podcast discussion on treating thrombosis in patients with cancer

Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis
  • download Downloadable
    Resouces
  • clock 27 MIN
  • calendar Sep 2023

Educational programme supported by an independent medical education grant from Viatris.
e-learning Interactive e-learning
Hemostasis and bleeding disorders 
Normalising Haemostasis in Haemophilia: Panel Discussion and E-learning

Will the expert panellists change the way you think about managing haemophilia?

Experts
Prof. Pål Andrè Holme, Prof. Niamh O'Connell, Assoc. Prof. Jan Blatný
  • download Downloadable
    Resouces
  • clock 45 MIN
  • calendar Sep 2023

Educational programme supported by an independent medical education grant from Sobi.
podcast Podcast

Episode

1

of 4

episode
Hemostasis and bleeding disorders 
Monitoring Anticoagulation: Yes or No?

A clinical discussion on anticoagulation monitoring

Experts
Prof. Dimitrios Tsakiris, Prof. Michael Nagler
  • download Downloadable
    Resouces
  • clock 20 MIN
  • calendar Aug 2023

Educational programme supported by an independent medical education grant from Viatris
video Video
Hemostasis and bleeding disorders 
How Coagulation Cascade Deficiencies Lead to Bleeding Disorders

A short video from bleeding disorder experts

Experts
Dr Vickie McDonald, Prof. Ana Boban
  • clock 4 MIN
  • calendar Jul 2023

Educational programme supported by an independent medical education grant from Takeda